Triple
T22457595
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Failure Mode and Effects Analysis |
E555154
|
entity |
| Predicate | usedInStandard |
P1587
|
FINISHED |
| Object | ISO 14971 |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ISO 14971 | Statement: [Failure Mode and Effects Analysis, usedInStandard, ISO 14971]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ISO 14971 Context triple: [Failure Mode and Effects Analysis, usedInStandard, ISO 14971]
-
A.
ISO 14971
chosen
ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
-
B.
ISO 13485
ISO 13485 is an international quality management standard that specifies requirements for organizations involved in the design, production, installation, and servicing of medical devices and related services.
-
C.
IEC 62366
IEC 62366 is an international standard that specifies a usability engineering process for medical devices to ensure safe and effective use by users.
-
D.
IEC 62304
IEC 62304 is an international standard that defines life cycle requirements for the development and maintenance of medical device software.
-
E.
ICH Q9 Quality Risk Management
ICH Q9 Quality Risk Management is an international guideline that provides a systematic, science- and risk-based approach to identifying, evaluating, and controlling quality risks throughout the lifecycle of pharmaceutical products.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e51fdec8190adfdf9f8a6362221 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b7d00208190955a70e2c22d25a4 |
completed | April 29, 2026, 1:14 a.m. |
Created at: April 16, 2026, 8:48 p.m.